Download presentation
Presentation is loading. Please wait.
Published byRobyn Fields Modified over 9 years ago
1
Two Bioassays for Cyanobacterial Neuro- active Metabolites Amanda Cordes, Dr. Doug Goeger, Dr. William Gerwick
2
The Gerwick Group Purpose: Study of marine algae to discover novel compounds and develop biomedicinal agents Focus: Marine Cyanobacteria = “blue green algae”
3
Antillatoxin Kalkitoxin Curacin A Anticancer agents Anesthetics Agrichemicals Discoveries:Applications: ∙ Nogle LM, Okino T, Gerwick WH. "Antillatoxin B, a neurotoxic lipopeptide from the marine cyanobacterium Lyngbya majuscula." Journal of Natural Products 2001, 64:983-985. ∙ Lu, W.I., F.W. Berman, T. Okino, F. Yokokawa, T. Shioiri, W.H. Gerwick, and T.F. Murray (2001) Antillatoxin is a novel marine cyanobacterial toxin that potently activates voltage- gated sodium channels. Proceedings of the National Academy of Sciences. (Submitted for publication). ∙ Milligan, K. E., B Marquez, R. T. Williamson, and W. H. Gerwick (2000) Lyngbyabellin B, a toxic and antifungal secondary metabolite from the marine cyanobacterium Lyngbya majuscula. J. Natural Products 63: 1440-1443. ∙ Verdier-Pinard, P., N. Sitachitta, J.V. Rossi, D.L. Sackett, W.H. Gerwick and E. Hamel (1999) Biosynthesis of radiolabeled curacin a and its rapid and apparently irreversible binding to the colchicine site of tubulin. Arch. Biochem. Biophys. 370: 51-58.
4
Part 1. Detection and Characterization of Cyanobacterial Neurotoxins using Zebrafish Behavior
5
Goals Determine viability of zebrafish as toxicity model using known neurotoxins Apply model to marine cyanobacterial extracts to detect biological activity and characterize their pharmacology
6
Zebrafish (Danio rerio) http://edtech.tph.wku.edu/~jbilotta/neuro.htm
7
Experiment Place fish in 100 mL of water Expose fish to toxin in increasing amounts until response is observed Isolate fish overnight to observe recovery Verify response on other fish In some cases, increase dose to obtain a more pronounced response
8
Amount of Toxin Required to Induce Response in 100 mL of Water Ethanol: 33 mg Ouabain: 3.27 mg Nicotine: 0.25 mg Caffeine: 0.68 mg Amount of Compound (mg)
9
Responses Observed Ethanol: Fish at bottom, often bouncing Ouabain: Fish circling, may also go to bottom Nicotine: Fish circling beaker at surface, tilted upwards, quivering Caffeine: Fish holding at bottom
10
Results of Blind Tests One compound per beaker, fish introduced simultaneously Ethanol, Ouabain, and Control: All three systems were correctly identified Ethanol, Ouabain, Nicotine, Caffeine, and Control: Only Nicotine was correctly identified
11
Conclusions on Zebrafish Model Fish to fish variability is high Large quantities of toxin required to induce response Zebrafish are not a viable model for detection and characterization of cyanobacterial neurotoxins
12
Part 2. Ability of Cyanobacterial Metabolites to Induce Neuritogenesis
13
Neuro 2a Neuroblastoma Cells: A mouse cancer cell line deriving from neurons Neuron: Cell with capability of transmitting electric signals, found in nervous system Neurite: Long, branching outgrowth from a neuron Differentiate: Cells mature, adopt distinctive functions, less likely to divide http://cancerweb.ncl.ac.uk First – Defining Some Terms
14
Neuro 2a Cells with Neurites http://users.jagunet.com/~meledy/cell2.jpg
15
Background Marine sponge compound Lembehyne A induces neuritogenesis Both Lactacystin and 8-Bromo-Cyclic AMP (8-Br-cAMP) also induce neuritogenesis ∙ Aoki, S., Matsui, K., Takata, T., Hong, W., and Kobayashi, M. (2001) Lembehyne A, a Spongean Polyacetylene, Induces Neuronal Differentiation in Neuroblastoma Cell. Biochem. Biophys Res Commun. 289, 558-563. ∙ Fenteany, G., and Schreiber, S. (1998) Lactacystin, Proteasome Function, and Cell Fate. J Biol. Chem. 273, 8545-8548.
16
Experiment Neuro 2a Cells are cultured in 60 mm dishes Cells then exposed to novel marine extracts, observed in 24 hr. increments Neurite outgrowth compared against untreated control cells and ones treated with Lactacystin and with 8-Br- cAMP, known outgrowth promoters
17
Neurite Outgrowth Controls Treated Control
18
Screening for Pure Cyanobacterial Natural Products that Induce Neurite Outgrowth Based on % of cells with outgrowths after 24 hours
19
Inactive Compounds Octadec-5-yne-7Z,9Z,12Z-trienoic Acid 10 ug/mL:0.65% 3 ug/mL:0.86% Malhamensilipin A 10 ug/mL:2.2% 3 ug/mL:2.% Avrainvilleol 10 ug/mL:2.2% 3 ug/mL:4.2%
20
Cont’d Gloiosiphone A Dimethyl Ether 10 ug/mL:2.6% 3 ug/mL:3.8% Pacifenol 10 ug/mL:0.68% 3 ug/mL:3.3% Dilophic Acid 10 ug/mL:1.2% 3 ug/mL:2.8%
21
Cont’d Cymathere Lactone 10 ug/mL:1.5% 3 ug/mL:2.4% Malyngolide 10 ug/mL:0.59% 3 ug/mL:2.8% Spiro-bis-pinnaketal 10 ug/mL:1.6% 3 ug/mL:2.4%
22
Cont’d Palisadin A 10 ug/mL:2.4% 3 ug/mL:2.9% Carmabin A 10 ug/mL:0% 3 ug/mL:2.8% Martensia Indole 10 ug/mL:0% 3 ug/mL:1.2%
23
Toxic Compounds Hormothamnione 10 ug/mL:toxic 3 ug/mL:1.1% Malyngamide F Acetate 10 ug/mL:toxic 3 ug/mL:toxic Ptilodene Methyl Ester 10 ug/mL:toxic 3 ug/mL:1.8%
24
Cont’d Cymopol 10 ug/mL:toxic 3 ug/mL:1.5%
25
Active Compounds Allolaurinterol 10ug/mL:3.3% 3ug/mL:6.2 %
26
Cont’d Methyl 12S-HETE 10ug/mL:2.3% 3ug/mL:5.4%
27
Cont’d Sarcolactone A 10ug/mL:3.7% 3ug/mL:5.6 %
28
Cont’d Sarcolactone B 10ug/mL:3.0% 3ug/mL:4.2%
29
Cont’d Ecklonialactone B 10ug/mL:4.7% 3ug/mL:4.2%
30
Cont’d Constanolactone A 10ug/mL:2.1% 3ug/mL:4.7%
31
Cont’d Lyngbya chlorohydrin (Higa) 10ug/mL:1.0% 3ug/mL:8.1%
32
Current and Future Plans Continue screening pure compounds Re-screen compounds showing activity Re-screen toxic compounds at lower concentrations Screen crude extracts and fractions from the Gerwick cyanobacterial library
33
Acknowledgements Howard Hughes Medical Institute Dr. Doug Goeger Dr. Bill Gerwick Mirjam Girt
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.